Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Aside from share buybacks, Cardinal Health is also paying a quarterly dividend to distribute cash to its shareholders.
Benjamin Edwards Inc. purchased a new stake in shares of Cardinal Health during the first quarter worth $27,000.
BlackRock Inc. grew its stake in shares of Cardinal Health by 25.9% in the third quarter.
Blair William & Co. IL lifted its stake in shares of Cardinal Health by 6.7% in the 1st quarter.
Canada Pension Plan Investment Board’s holdings in Cardinal Health were worth $8,684,000 as of its most recent SEC filing.
Comerica Bank’s holdings in Cardinal Health were worth $5,561,000 as of its most recent SEC filing.
CoreCap Advisors LLC bought a new position in Cardinal Health in the 2nd quarter worth $243,000.
Source: https://www.dailypolitical.com/2023/01/09/cardinal-health-nysecah-pt-raised-to-86-00.html
Equities research analysts expect that Cardinal Health, Inc. will post 6.89 earnings per share for the current fiscal year.
Exchange Traded Concepts LLC lifted its stake in Cardinal Health, Inc. () by 1,175.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission.
Finally, Boyd Watterson Asset Management LLC OH acquired a new stake in Cardinal Health during the 4th quarter worth $40,000.
Finally, Callahan Advisors LLC raised its stake in Cardinal Health by 35.1% during the 2nd quarter.
In January, a well-attended Opioid Solutions Forum was hosted by the Valparaiso City Council to gather information for the use of funding provided as part of a national settlement with Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKesson.
In the previous years, investor sentiment drove Cardinal Health to unjustified low valuation multiples and as the stock was clearly undervalued a reversion to the mean was reasonable (and had to be expected at some point).
JPMorgan Chase & Co. Increases Cardinal Health (NYSE:CAH) Price Target to $93.
Mizuho upped their price objective on Cardinal Health from $94.00 to $96.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 16th.
Moneta Group Investment Advisors LLC acquired a new stake in Cardinal Health during the fourth quarter valued at approximately $215,893,000.
Robert W. Baird lifted their price objective on shares of Cardinal Health from $97.00 to $103.00 in a research note on Friday, June 9th.
Stonebridge Capital Advisors LLC Invests $29,000 in Cardinal Health, Inc.